CompaniesApoCell

ApoCell

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

5,291

By Phase

PHASE1: 1

By Status

COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT00578240
Hover over trial bars to see details

Recent Trials

NCT02935790Collaborator
Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab
PHASE1Completed
1 participants
Started: Sep 30, 2016 · Completed: Apr 7, 2017
NCT00578240Collaborator
Molecular Studies and Clinical Correlations in Human Prostatic Disease
N/AActive, not recruiting
5,290 participants
Started: Apr 30, 1990 · Completed: Dec 31, 2026
Related Companies
Precision For Medicine
acquired